The fusion of AI and life sciences is set to revolutionize drug discovery. OpenAI's Miles Wang is pushing boundaries with a new AI startup, signaling an era of breakthroughs. Valued at $2B, this venture reflects a growing trust in AI's potential to innovate in healthcare. How might this reshape drug discovery as we know it? #AI #HealthcareInnovation #DrugDiscovery

#AI #HealthcareInnovation #DrugDiscovery